Schedule 13G ownership disclosure
Definium Therapeutics Inc
Common Stock · CUSIP: 24477V105
Event date: 2026-09-30
- Filing-level shares
- 8,255,584.00
- Percent of class
- 6.1%
- Capital World Investors
Shares: 8,255,584.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-26-000171
- Form type
- SCHEDULE 13G
- Filer
- Definium Therapeutics, Inc.
- CIK
- CIK 1813814
- Filed
- Nov 13, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership